Scangos grabs the spotlight amid Biogen Idec's surge; Sanofi exec talks up data transparency;

 @FierceBiotech: In Alzheimer's mystery, key biomarker will determine success of pivotal studies. Story | Follow @FierceBiotech

@JohnCFierce: At the very least, Merck should redesign the patient selection process on MK-8931 and concentrate on mild/prodromal Alzheimer's cases only. | Follow @JohnCFierce

 @RyanMFierce: AstraZeneca has answered German price cuts to drugs with $AZN workforce cuts of 400-650 workers in the country. Release | Follow @RyanMFierce

> Lundbeck CEO Ulf Wiinberg predicts 2013 to bring a "feast" of potential regulatory wins after battling generics competition. Article

> Biogen Idec ($BIIB) CEO George Scangos is featured in a Forbes article on the big biotech's comeback. Item

> FDA staff out the potential for abuse of Zogenix's pain drug. Item

> Peregrine ($PPHM) says (again) that the FDA has cleared the company's plans for late-stage development of Cotara for treating brain tumors. Report

> GlaxoSmithKline ($GSK) has raised doubts about diabetes drugs in the GLP-1 class serving as obesity treatments. Article

Pharma News

@FiercePharma: Eli Lilly taps India's Strides Arcolab to make/distribute generic cancer drugs in emerging markets. More | Follow @FiercePharma

> Indian bureaucrats decide to review all foreign pharma investments. More

> Closely watched Novartis patent case wraps in India. Story

> AZ blames German pricing for 400 job cuts. Article

Medical Device News

 @FierceMedDev: SurgiQuest pulled in $18.5M in new funding for an abdominal cavity surgical tool. Release | Follow @FierceMedDev

@MarkHFierce: Another day, another lawsuit against a faulty metal hip replacement--this time against Biomet. Story | Follow @MarkHFierce

 @DamianFierce: The Israeli medical device industry is on the up-and-up, and Medtronic is paying attention, an exec says. News | Follow @DamianFierce

> Device startup nails $3.64M Series A for hemorrhage-control device. Item

> Kona Medical closes $40M round for renal denervation device. News

Drug Delivery News

> Leukemia nanoparticles get drugs to the right spot. News

> Team shoos away superbugs with puffs of powder. Report

> Iluvien stumbles on rocky road to market in U.K. Article

> Dissolving fabric could stop pregnancy, HIV. Story

Biomarkers News

> Experts: Britain's NHS must build genetic testing infrastructure. News

> In Alzheimer's mystery, key biomarker will determine success of pivotal studies. Article

> Supreme Court to tackle gene patent case. Item

> Gene analysis marks new targets against childhood cancer. Report

> Biotech grabs $2M to discover biomarkers for personalized autism treatment. News

> Biomarker spotted for colon cancer stem cells. Story

And Finally… Sanofi ($SNY) strategy chief David-Alexandre Gros has joined the small but growing number of pharma execs talking up transparency of raw data from clinical trials. Report

Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.